Mason Street Advisors’s Regeneron Pharmaceuticals REGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-14,465
Closed -$6.99M 990
2020
Q4
$6.99M Sell
14,465
-218
-1% -$118K 0.12% 153
2020
Q3
$8.22M Buy
14,683
+283
+2% +$172K 0.16% 109
2020
Q2
$8.98M Buy
14,400
+3,003
+26% +$1.7M 0.18% 94
2020
Q1
$5.57M Hold
11,397
0.13% 148
2019
Q4
$4.28M Buy
11,397
+13
+0.1% +$4.37K 0.08% 245
2019
Q3
$3.16M Buy
11,384
+168
+1% +$49.7K 0.07% 338
2019
Q2
$3.51M Buy
11,216
+34
+0.3% +$11.3K 0.07% 294
2019
Q1
$4.59M Buy
11,182
+239
+2% +$98.4K 0.09% 216
2018
Q4
$4.09M Buy
10,943
+50
+0.5% +$18.3K 0.1% 194
2018
Q3
$4.4M Buy
10,893
+41
+0.4% +$15.6K 0.09% 219
2018
Q2
$3.74M Buy
10,852
+95
+0.9% +$29.7K 0.08% 244
2018
Q1
$3.7M Buy
10,757
+27
+0.3% +$9.39K 0.08% 252
2017
Q4
$4.03M Buy
10,730
+65
+0.6% +$26.3K 0.09% 224
2017
Q3
$4.77M Buy
10,665
+90
+0.9% +$42.8K 0.11% 168
2017
Q2
$5.19M Buy
10,575
+66
+0.6% +$28.9K 0.13% 142
2017
Q1
$4.07M Buy
10,509
+168
+2% +$62.3K 0.1% 195
2016
Q4
$3.8M Buy
10,341
+132
+1% +$50.2K 0.1% 199
2016
Q3
$4.1M Sell
10,209
-297
-3% -$119K 0.12% 170
2016
Q2
$3.67M Buy
10,506
+106
+1% +$40.8K 0.11% 183
2016
Q1
$3.75M Buy
10,400
+258
+3% +$106K 0.11% 172
2015
Q4
$5.51M Buy
10,142
+138
+1% +$74.8K 0.17% 114
2015
Q3
$4.65M Buy
10,004
+296
+3% +$159K 0.16% 125
2015
Q2
$4.95M Buy
9,708
+207
+2% +$101K 0.15% 132
2015
Q1
$4.29M Sell
9,501
-23,380
-71% -$9.91M 0.13% 157
2014
Q4
$13.5M Sell
32,881
-23
-0.1% -$9.04K 0.09% 260
2014
Q3
$11.9M Sell
32,904
-1,005
-3% -$337K 0.09% 263
2014
Q2
$9.58M Sell
33,909
-6,436
-16% -$1.91M 0.07% 331
2014
Q1
$12.1M Buy
40,345
+7,060
+21% +$2.18M 0.1% 254
2013
Q4
$9.16M Sell
33,285
-1,594
-5% -$458K 0.07% 314
2013
Q3
$10.9M Sell
34,879
-23,381
-40% -$6.15M 0.12% 216
2013
Q2
$13.1M Buy
+58,260
New +$13.6M 0.14% 202

Other funds holding REGN